AbbVie Inc. Stock Rises Friday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) inched 0.60% higher to $145.28 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.36% to 3,770.55 and the Dow Jones Industrial Average rising 1.26% to 32,403.22. The stock's rise snapped a two-day losing streak. AbbVie Inc. closed $30.63 short of its 52-week high ($175.91), which the company achieved on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Pfizer Inc. (PFE) rose 1.40% to $47.22, Eli Lilly & Co. (LLY) fell 1.18% to $357.41, and AstraZeneca PLC ADR (AZN.LN) rose 1.77% to $60.99. Trading volume (4.6 M) remained 919,938 below its 50-day average volume of 5.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2022.
(END) Dow Jones Newswires
November 04, 2022 16:33 ET (20:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.